Clinical Trial Update: Biomarkers Predicting Successful Tacrolimus Withdrawal and Everolimus (Zortress) Monotherapy Early After Liver Transplantation [NA]

View source ↗

Summary

Clinical trial update on biomarkers predicting successful tacrolimus withdrawal and everolimus monotherapy early after liver transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Everolimus (everolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Northwestern University | Conditions: Liver Transplantation | NA | Status: COMPLETED | Results posted: 2022-10-07